[CONTRIBUTION TO THE STUDY OF THE LYELL SYNDROME].
D000632:Aminopyrine; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D003875:Drug Eruptions; D006261:Headache; D006801:Humans; D007251:Influenza, Human; D009437:Neuralgia; D010612:Pharyngitis; D010653:Phenylbutazone; D011398:Promethazine; D011804:Quinolines; D012216:Rheumatic Diseases; D013262:Stevens-Johnson Syndrome; D014069:Tonsillitis; D014116:Toxicology
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D011804:Quinolines; D000632:Aminopyrine; D011398:Promethazine; D010653:Phenylbutazone
AMINOPYRINE; ANALGESICS AND ANTIPYRETICS; ARTHRITIS, RHEUMATOID; DERMATITIS MEDICAMENTOSA; EPIDERMAL NECROLYSIS, TOXIC; HEADACHE; INFLUENZA; NEURALGIA; PHARYNGITIS; PHENYLBUTAZONE; PROMETHAZINE; QUINOLINES; REVIEW; RHEUMATISM; TONSILLITIS; TOXICOLOGIC REPORT
CONTRIBUTO ALL STUDIO DELLA SINDROME DI LYELL.